CRVO - CIK 0001053691
The table below shows CervoMed Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.02M | -$3.89M | -$1.42M | -$1.48M | -$4.73M | -$5.18M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | $7.71M | $5.40M | $0.00 | $9.50M | -$22.72M | $0.00 |
| Dividends paid | - | - | - | - | - |
CervoMed Inc. reported operating cash flow of -$23.45M for fiscal year 2025. That is down 41.9% from -$16.53M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$10.77M (FY 2016) to -$23.45M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $13.80K | $0.00 | - | $0.00 | $5.00K | $33.30M |